Mechanism of action of pre-meal consumption of whey protein on glycemic control in young adults

Journal of Nutritional Biochemistry

Volumn 25, Issue 1, 2014, Pages 36-43

  Akhavan, Tina ^a   Luhovyy, Bohdan L ^a   Panahi, Shirin ^a   Kubant, Ruslan ^a   Brown, Peter H ^b   Anderson, G Harvey ^a  

^a UNIVERSITY OF TORONTO   (Canada)

^b Kraft Foods Global LLCUS   (Canada)

Author keywords

Blood glucose; Gastric emptying; GLP 1; Insulin; Whey protein consumption

Indexed keywords

AMYLIN; C PEPTIDE; CHOLECYSTOKININ; GASTRIC INHIBITORY POLYPEPTIDE; GHRELIN; GLUCAGON LIKE PEPTIDE 1; GLUCOSE; INCRETIN; INSULIN; MILK PROTEIN; PARACETAMOL; PEPTIDE YY; WATER;

ADULT; ARTICLE; CONTROLLED STUDY; FOOD INTAKE; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HUMAN; HUMAN EXPERIMENT; INSULIN RELEASE; MALE; MEAL; NORMAL HUMAN; PROTEIN BLOOD LEVEL; PROTEIN INTAKE; STOMACH EMPTYING;

BLOOD GLUCOSE; GASTRIC EMPTYING; GLP-1; INSULIN; WHEY PROTEIN CONSUMPTION;

ADOLESCENT; ADULT; BLOOD GLUCOSE; BODY MASS INDEX; BODY WEIGHT; C-PEPTIDE; CHOLECYSTOKININ; CROSS-OVER STUDIES; GASTRIC EMPTYING; GASTRIC INHIBITORY POLYPEPTIDE; GASTROINTESTINAL HORMONES; GLUCAGON-LIKE PEPTIDE 1; HUMANS; INSULIN; ISLET AMYLOID POLYPEPTIDE; MALE; MILK PROTEINS; PEPTIDE YY; YOUNG ADULT;

EID: 84889567985     PISSN: 09552863     EISSN: 18734847     Source Type: Journal    
DOI: 10.1016/j.jnutbio.2013.08.012     Document Type: Article

References (46)

1. Gannon M.C., Nuttall F.Q., Neil B.J., Westphal S.A. The insulin and glucose responses to meals of glucose plus various proteins in type II diabetic subjects. Metabolism 1988, 37(11):1081-1088.
2. Karamanlis A., Chaikomin R., Doran S., Bellon M., Bartholomeusz F.D., Wishart J.M., et al. Effects of protein on glycemic and incretin responses and gastric emptying after oral glucose in healthy subjects. Am J Clin Nutr 2007, 86(5):1364-1368.
3. Frid A.H., Nilsson M., Holst J.J., Bjorck I.M. Effect of whey on blood glucose and insulin responses to composite breakfast and lunch meals in type 2 diabetic subjects. Am J Clin Nutr 2005, 82(1):69-75.
4. Petersen B.L., Ward L.S., Bastian E.D., Jenkins A.L., Campbell J., Vuksan V. A whey protein supplement decreases post-prandial glycemia. Nutr J 2009, 8:47.
5. Akhavan T., Panahi S., Anderson G.H., Luhovyy B.L. Application of dairy-derived ingredients in food intake and metabolic regulation 2009, 212-237. Woodhead Publishing Ltd, Cambridge, UK. M. Corredig (Ed.).
6. Luhovyy B.L., Akhavan T., Anderson G.H. Whey proteins in the regulation of food intake and satiety. J Am Coll Nutr 2007, 26(6):704S-712S.
7. Jakubowicz D., Froy O. Biochemical and metabolic mechanisms by which dietary whey protein may combat obesity and Type 2 diabetes. J Nutr Biochem 2013, 24(1):1-5.
8. Lan-Pidhainy X., Wolever T.M. The hypoglycemic effect of fat and protein is not attenuated by insulin resistance. Am J Clin Nutr 2010, 91(1):98-105.
9. Boirie Y., Dangin M., Gachon P., Vasson M.P., Maubois J.L., Beaufrere B. Slow and fast dietary proteins differently modulate postprandial protein accretion. Proc Natl Acad Sci U S A 1997, 94(26):14930-14935.
10. Nilsson M., Holst J.J., Bjorck I.M. Metabolic effects of amino acid mixtures and whey protein in healthy subjects: studies using glucose-equivalent drinks. Am J Clin Nutr 2007, 85(4):996-1004.
11. Pal S., Ellis V. The acute effects of four protein meals on insulin, glucose, appetite and energy intake in lean men. Br J Nutr 2010, 104(8):1241-1248.
12. Hall W.L., Millward D.J., Long S.J., Morgan L.M. Casein and whey exert different effects on plasma amino acid profiles, gastrointestinal hormone secretion and appetite. Br J Nutr 2003, 89(2):239-248.
13. Akhavan T., Luhovyy B.L., Brown P.H., Cho C.E., Anderson G.H. The effect of pre-meal consumption of whey protein and its hydrolysate on food intake and post-meal glycemia and insulin responses in young adults. Am J Clin Nutr 2010, 91(4):966-975.
14. Ma J., Stevens J.E., Cukier K., Maddox A.F., Wishart J.M., Clifton P.M., et al. Effects of a protein 'preload' on gastric emptying, glycemia, and gut hormones after a carbohydrate meal in diet-controlled type 2 diabetes. Diabetes Care 2009, 32(9):1600-1602.
15. Herman C.P., Polivy J. Restrained eating. Obesity Philadelphia 1980, 208-217. WB Saunders and Co, PA. A.J. Stunkard (Ed.).
16. Akhavan T., Anderson G.H. Effects of glucose-to-fructose ratios in solutions on subjective satiety, food intake, and satiety hormones in young men. Am J Clin Nutr 2007, 86(5):1354-1363.
17. Claessens M., Saris W.H., van Baak M.A. Glucagon and insulin responses after ingestion of different amounts of intact and hydrolysed proteins. Br J Nutr 2008, 100(1):61-69.
18. Hamedani A., Akhavan T., Samra R.A., Anderson G.H. Reduced energy intake at breakfast is not compensated for at lunch if a high-insoluble-fiber cereal replaces a low-fiber cereal. Am J Clin Nutr 2009, 89(5):1343-1349.
19. Hovorka R., Soons P.A., Young M.A. ISEC: a program to calculate insulin secretion. Comput Methods Programs Biomed 1996, 50(3):253-264.
20. Polonsky K.S., Rubenstein A.H. C-peptide as a measure of the secretion and hepatic extraction of insulin. Pitfalls and limitations. Diabetes Metab 1984, 33:486-494.
21. Nauck M.A., Niedereichholz U., Ettler R., Holst J.J., Orskov C., Ritzel R., et al. Glucagon-like peptide 1 inhibition of gastric emptying outweighs its insulinotropic effects in healthy humans. Am J Physiol 1997, 273(5 Pt 1):E981-E988.
22. Allen J.M., Fitzpatrick M.L., Yeats J.C., Darcy K., Adrian T.E., Bloom S.R. Effects of peptide YY and neuropeptide Y on gastric emptying in man. Digestion 1984, 30(4):255-262.
23. Drucker D.J., Shi Q., Crivici A., Sumner-Smith M., Tavares W., Hill M., et al. Regulation of the biological activity of glucagon-like peptide 2 in vivo by dipeptidyl peptidase IV. Nat Biotechnol 1997, 15:673-677.
24. Eberlein G.A., Eysselein V.E., Schaeffer M., et al. A new molecular form of PYY: structural characterization of human PYY(3-36) and PYY(1-36). Peptides 1989, 10(4):797-803.
25. Gunnarsson P.T., Winzell M.S., Deacon C.F., Larsen M.O., Jelic K., Carr R.D., et al. Glucose-induced incretin hormone release and inactivation are differently modulated by oral fat and protein in mice. Endocrinology 2006, 147(7):3173-3180.
26. Schmidtler J., Dehne K., Allescher H.-D., Schusdziarra V., Classen M., Holst J.J., et al. Rat parietal cell receptors for GLP-1-(7-36) amide: Northern blot, cross-linking, and radioligand binding. Am J Physiol 1994, 267(3 Pt 1):G423-G432.
27. Baggio L.L., Huang Q., Brown T.J., Drucker D.J. A recombinant human glucagon-like peptide (GLP)-1-albumin protein (albugon) mimics peptidergic activation of GLP-1 receptor-dependent pathways coupled with satiety, gastrointestinal motility, and glucose homeostasis. Diabetes Metab 2004, 53(9):2492-2500.
28. Butler P.C., Chou J., Carter W.B., Wang Y.N., Bu B.H., Chang D., et al. Effects of meal ingestion on plasma amylin concentration in NIDDM and nondiabetic humans. Diabetes 1990, 39(6):752-756.
29. Whitehouse F., Kruger D.F., Fineman M., Shen L., Ruggles J.A., Maggs D.G., et al. A randomized study and open-label extension evaluating the long-term efficacy of pramlintide as an adjunct to insulin therapy in type 1 diabetes. Diabetes Care 2002, 25(4):724-730.
30. Wang F., Adrian T.E., Westermark G.T., Ding X., Gasslander T., Permert J. Islet amyloid polypeptide tonally inhibits beta-, alpha-, and delta-cell secretion in isolated rat pancreatic islets. Am J Physiol 1999, 276(1 Pt 1):E19-E24.
31. Wang Z.L., Bennet W.M., Ghatei M.A., Byfield P.G., Smith D.M., Bloom S.R. Influence of islet amyloid polypeptide and the 8-37 fragment of islet amyloid polypeptide on insulin release from perifused rat islets. Diabetes 1993, 42(2):330-335.
32. Degano P., Silvestre R.A., Salas M., Peiro E., Marco J. Amylin inhibits glucose-induced insulin secretion in a dose-dependent manner. Study in the perfused rat pancreas. Regul Pept 1993, 43(1-2):91-96.
33. Karhunen L.J., Juvonen K.R., Huotari A., Purhonen A.K., Herzig K.H. Effect of protein, fat, carbohydrate and fibre on gastrointestinal peptide release in humans. Regul Pept 2008, 149(1-3):70-78.
34. Reidelberger R.D., Arnelo U., Granqvist L., Permert J. Comparative effects of amylin and cholecystokinin on food intake and gastric emptying in rats. Am J Physiol Regul Integr Comp Physiol 2001, 280(3):R605-R611.
35. Gedulin B.R., Rink T.J., Young A.A. Dose-response for glucagonostatic effect of amylin in rats. Metab Clin Exp 1997, 46(1):67-70.
36. Nakabayashi H., Nishizawa M., Nakagawa A., Takeda R., Niijima A. Vagal hepatopancreatic reflex effect evoked by intraportal appearance of tGLP-1. Am J Physiol 1996, 271(5 Pt 1):E808-E813.
37. Drucker D.J. The biology of incretin hormones. Cell Metab 2006, 3(3):153-165.
38. van den Hoek A.M., Heijboer A.C., Corssmit E.P., Voshol P.J., Romijn J.A., Havekes L.M., et al. PYY3-36 reinforces insulin action on glucose disposal in mice fed a high-fat diet. Diabetes Metab 2004, 53(8):1949-1952.
39. Vrang N., Madsen A.N., Tang-Christensen M., Hansen G., Larsen P.J. PYY(3-36) reduces food intake and body weight and improves insulin sensitivity in rodent models of diet-induced obesity. Am J Physiol Regul Integr Comp Physiol 2006, 291(2):R367-R375.
40. Bowen J., Noakes M., Clifton P.M. Appetite hormones and energy intake in obese men after consumption of fructose, glucose and whey protein beverages. Int J Obes (Lond) 2007, 31(11):1696-1703.
41. Callahan H.S., Cummings D.E., Pepe M.S., Breen P.A., Matthys C.C., Weigle D.S. Postprandial suppression of plasma ghrelin level is proportional to ingested caloric load but does not predict intermeal interval in humans. J Clin Endocrinol Metab 2004, 89(3):1319-1324.
42. Sanaka M., Kuyama Y., Yamanaka M. Guide for judicious use of the paracetamol absorption technique in a study of gastric emptying rate of liquids. J Gastroenterol 1998, 33(6):785-791.
43. Willems M., Quartero A.O., Numans M.E. How useful is paracetamol absorption as a marker of gastric emptying? A systematic literature study. Dig Dis Sci 2001, 46(10):2256-2262.
44. Naslund E., Bogefors J., Gryback P., Jacobsson H., Hellstrom P.M. Gastric emptying: comparison of scintigraphic, polyethylene glycol dilution, and paracetamol tracer assessment techniques. Scand J Gastroenterol 2000, 35(4):375-379.
45. Deane A.M., Fraser R.J., Chapman M.J. Prokinetic drugs for feed intolerance in critical illness: current and potential therapies. Crit Care Resusc 2009, 11(2):132-143.
46. Asakawa A., Inui A., Fujimiya M., Sakamaki R., Shinfuku N., Ueta Y., et al. Stomach regulates energy balance via acylated ghrelin and desacyl ghrelin. Gut 2005, 54(1):18-24.